Mendelian randomization (MR) is transforming how scientists uncover causal links in health research by using genetic variants as natural experiments. Recent advances are tackling challenges like rare ...

The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...

Researchers at UNSW Sydney have pinpointed genes that may play a causal role in vascular dementia, offering promising leads for drug development. The study used Mendelian randomization to analyze over ...

Researchers at Columbia University Mailman School of Public Health have developed a novel computational pipeline designed to identify protein biomarkers associated with complex diseases, including ...